Back to News
Market Impact: 0.15
Larimar Therapeutics Names John Harlow As President And COO
Source: Nasdaq
Healthcare & BiotechManagement & Governance
Larimar Therapeutics appointed John Harlow as President and Chief Operating Officer, effective September 29, 2026. Harlow will report to CEO Carole Ben-Maimon; the announcement provides no financial, clinical, or strategic guidance details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment
LRMR0.20
More News
- California Gov. Gavin Newsom bans AI 'robo bosses' in landmark state law, reversing his earlier veto
- The new and huger Paramount has a new co-CEO
- US judge approves settlement allowing Paramount to acquire Warner Bros
- Why is Nidec stock plunging today?
- Nidec Corp shares slump after auditor declines to sign off on earnings
- David Ellison names Ynon Kreiz co-CEO of Paramount and Warner Bros. Discovery